Homocysteine and Hydroxyproline Levels in Patients with Primary Open-Angle Glaucoma

REFERENCES

• Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483–3493.
   PubMed Web of Science ®Google Scholar
• Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001;64:523–532.
   PubMed Web of Science ®Google Scholar
• Fuchsjäger-Mayrl G, Wally B, Georgopoulos M et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004;45:834–839.
   PubMed Web of Science ®Google Scholar
• Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73:45–57.
   PubMed Web of Science ®Google Scholar
• Carroll JF, Tyagi SC. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens. 2005;18:692–698.
   PubMed Web of Science ®Google Scholar
• Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res. 2010;35:295–301.
   PubMed Web of Science ®Google Scholar
• Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781.
   PubMed Web of Science ®Google Scholar
• Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology. 2005;112:2076–2080.
   PubMed Web of Science ®Google Scholar
• Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588–1592.
   PubMed Web of Science ®Google Scholar
• Marcucci R, Bertini L, Giusti B et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost. 2001;86:772–776.
   PubMed Web of Science ®Google Scholar
• Bleich S, Roedl J, Von Ahsen N et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162–164.
   PubMed Web of Science ®Google Scholar
• Refsum H, Smith AD, Ueland PM et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3–32.
   PubMed Web of Science ®Google Scholar
• Wang G, Medeiros FA, Barshop BA, Weinreb RN. Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol. 2004;137:401–406.
   PubMed Web of Science ®Google Scholar
• Clarke R, Stansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann Clin Biochem. 2001;38:624–632.
   PubMed Web of Science ®Google Scholar
• Pihlajaniemi T, Myllylä R, Kivirikko KI. Prolyl 4-hydroxylase and its role in collagen synthesis. J Hepatol. 1991;13 Suppl 3:S2–S7.
   PubMedGoogle Scholar
• Eroshevskii TI, Sviatkovskaia TIa. [Study of serum hydroxyproline in healthy persons and in patients with primary glaucoma in relation to age]. Oftalmol Zh. 1977;32:101–103.
   PubMedGoogle Scholar
• Ozyurt H, Totan A, Sahin S, Kilinç C, Sögüt S, Akyol O. Maternal serum and amniotic fluid hydroxyproline levels in neural tube defects. Fetal Diagn Ther. 2003;18:321–323.
   PubMed Web of Science ®Google Scholar
• Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440–447.
   PubMed Web of Science ®Google Scholar
• Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997;115:1031–1035.
   PubMed Web of Science ®Google Scholar
• Roedl JB, Bleich S, Reulbach U et al. Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma. J Neural Transm. 2007;114:445–450.
   PubMed Web of Science ®Google Scholar
• Wang G, Medeiros FA, Barshop JM, et al. Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol. 2004;137:401–406.
   PubMed Web of Science ®Google Scholar
• Altintas O, Maral H, Yüksel N, Karabas VL, Dillioglugil MO, Caglar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:677–683.
   PubMed Web of Science ®Google Scholar
• Turgut B, Kaya M, Arslan S, Demir T, Güler M, Kaya MK. Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging. 2010;5:133–139.
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol. 2006;6:6.
   PubMedGoogle Scholar
• Bleich S, Jünemann A, von Ahsen N et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 2002;109:1499–1504.
   PubMed Web of Science ®Google Scholar
• Clement CI, Goldberg I, Healey PR, Graham SL. Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma. J Glaucoma. 2009;18:73–78.
   PubMed Web of Science ®Google Scholar
• Stamler JS, Osborne JA, Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308–318.
   PubMed Web of Science ®Google Scholar
• Tang L, Mamotte CD, Van Bockxmeer FM, Taylor RR. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis. 1998;136:169–173.
   PubMed Web of Science ®Google Scholar
• Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895–901.
   PubMed Web of Science ®Google Scholar
• Kirwan RP, Leonard MO, Murphy M, Clark AF, O’Brien CJ. Transforming growth factor-β-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia. 2005;52:309–324.
   PubMed Web of Science ®Google Scholar
• Küchle M, Ho TS, Nguyen NX, Hannappel E, Naumann GO. Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest Ophthalmol Vis Sci. 1994;35:748–752.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol. 1999;300:3–12.
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Makita N, Roberts LJ 2nd, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:C1619–C1624.
   PubMed Web of Science ®Google Scholar
• Lahaie I, Hardy P, Hou X et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 α on retinal vessels. Am J Physiol. 1998;274:R1406–R1416.
   PubMed Web of Science ®Google Scholar